Morgan Stanley
LUNG icon

Morgan Stanley’s Pulmonx LUNG Stock Holding History

Morgan Stanley’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.15M Sell
3,993,562
-166,907
-4% -$276K ﹤0.01% 4116
2025
Q4 		$9.19M Buy
4,160,469
+539,793
+15% +$1.01M ﹤0.01% 3681
2025
Q3 		$5.87M Buy
3,620,676
+63,628
+2% +$133K ﹤0.01% 4018
2025
Q2 		$9.21M Buy
3,557,048
+62,919
+2% +$248K ﹤0.01% 3515
2025
Q1 		$23.5M Buy
3,494,129
+421,291
+14% +$2.98M ﹤0.01% 2531
2024
Q4 		$20.9M Sell
3,072,838
-716,107
-19% -$4.72M ﹤0.01% 2704
2024
Q3 		$31.4M Buy
3,788,945
+317,868
+9% +$2.3M ﹤0.01% 2318
2024
Q2 		$22M Buy
3,471,077
+819,632
+31% +$6.3M ﹤0.01% 2557
2024
Q1 		$24.6M Sell
2,651,445
-1,905,997
-42% -$22.3M ﹤0.01% 2473
2023
Q4 		$58.1M Buy
4,557,442
+2,337,616
+105% +$24.4M ﹤0.01% 2282
2023
Q3 		$22.9M Buy
2,219,826
+246,302
+12% +$2.85M ﹤0.01% 2309
2023
Q2 		$25.9M Sell
1,973,524
-640,847
-25% -$7.84M ﹤0.01% 2207
2023
Q1 		$29.2M Buy
2,614,371
+463,866
+22% +$4.58M ﹤0.01% 2035
2022
Q4 		$18.1M Buy
2,150,505
+296,682
+16% +$2.82M ﹤0.01% 2441
2022
Q3 		$30.9M Sell
1,853,823
-273,948
-13% -$5.04M ﹤0.01% 1743
2022
Q2 		$31.3M Buy
2,127,771
+1,897,698
+825% +$39.1M ﹤0.01% 1796
2022
Q1 		$5.71M Buy
230,073
+163,024
+243% +$4.21M ﹤0.01% 3545
2021
Q4 		$2.15M Buy
67,049
+48,171
+255% +$1.76M ﹤0.01% 4527
2021
Q3 		$680K Sell
18,878
-46,158
-71% -$1.82M ﹤0.01% 5311
2021
Q2 		$2.87M Buy
65,036
+20,533
+46% +$894K ﹤0.01% 4325
2021
Q1 		$2.04M Buy
44,503
+30,316
+214% +$1.74M ﹤0.01% 4246
2020
Q4 		$979K Buy
+14,187
New +$695K ﹤0.01% 4684

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Morgan Stanley's LUNG Position: Q1 2026 in Review

Morgan Stanley reduced its Pulmonx (LUNG) stake by 4% in Q1 2026, selling an estimated $276K and leaving 3,993,562 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4116.

Morgan Stanley first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $58.1M in Q4 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Morgan Stanley held 3,993,562 shares of Pulmonx worth $5.15M as of Q1 2026.
  • Morgan Stanley sold 166,907 Pulmonx shares in Q1 2026, an estimated $276K.
  • Pulmonx made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4116 holding.
  • Morgan Stanley first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Morgan Stanley's Pulmonx position peaked at $58.1M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.